GIS

About GIS

This author has not yet filled in any details.
So far GIS has created 51 blog entries.

Health Canada Approves Stelara®

HEALTH CANADA APPROVES STELARA® FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE STELARA® offers a new approach to treating Crohn’s disease in Canada, which has one of the highest rates of this inflammatory bowel disease worldwide1 CNW – TORONTO, ON (December 14, 2016) — Janssen Inc. announced today that Health Canada [...]

By | December 16, 2016|News|

IBD Unmasked

Recognizing the heroic journey of people living with IBD We are proud to support the Canadian launch of IBD Unmasked, a first-of-its kind global awareness initiative developed though a unique collaboration between Takeda and the creative geniuses at Marvel Custom Solutions to support and empower the Inflammatory Bowel Disease (IBD) community. This unique initiative was [...]

By | December 7, 2016|News|

IBS Survey Results

Background The GI (Gastrointestinal) Society represents Canadians living with gastrointestinal diseases and disorders including those who have irritable bowel syndrome (IBS). We offer patient education on a wide array of GI conditions in text and video formats that covers the disease or disorder processes and provides descriptions of treatments available. The Society advocates to ensure [...]

By | December 6, 2016|News|

IBS Survey Follow-Up

Earlier this year, we created a survey for irritable bowel syndrome (IBS) patients, to help better understand how IBS affects people. Nearly 3,000 individuals responded, in both English and French. We will have the results of this survey available soon. In the meantime, if you were one of the respondents, or if you didn't fill [...]

By | November 30, 2016|News|

Takeda’s IBD Treatment ENTYVIO® (vedolizumab) Receives Prestigious Prix Galien Canada Innovative Product Award

OAKVILLE, ON, Nov. 23, 2016 /CNW/ - Takeda Canada is pleased to announce that ENTYVIO® (vedolizumab), a gut-selective biologic treatment to treat the two most common types of inflammatory bowel disease (IBD), has been named the 2016 winner of the prestigious Prix Galien Canada Innovative Product Award. The annual award, presented at a gala ceremony in [...]

By | November 29, 2016|News|

Nova Scotia – Patients First

The GI Society's CEO wrote a letter to the editor at a Halifax newspaper, the Chronicle Herald, about Nova Scotia’s new medication coverage guidelines. We are pleased with Nova Scotia's new patients first policy, which will help make sure patients with inflammatory bowel disease can continue taking medications that work for them.   Read the [...]

By | November 10, 2016|News|

Diverticular Disease Video

Watch our diverticular disease video below or click here to watch the video on YouTube. Diverticular Disease Video Transcript Diverticular disease, also known as diverticulosis, is the presence of small sac-like out-pouchings of the colon lining that balloon through the outer colon wall, called diverticula. Diverticulosis can be present without noticeable symptoms, but might be associated [...]

By | November 1, 2016|News|

GI Society launches new stomach cancer support group

Vancouver, BC – 4 October 2016 – The GI (Gastrointestinal) Society is proud to offer a new support group dedicated exclusively for individuals living with or recovering from stomach (gastric) cancer as well as their loved ones. “A stomach cancer diagnosis often results in emotional stress and a myriad of questions from the person with [...]

By | October 4, 2016|News|

Video: Clostridium difficile Infection

The human digestive tract is home to an estimated 500 to 1,000 different species of microorganisms, most of which are harmless, or even helpful, and live in harmony. If something upsets the balance, such as treatment with antibiotics or cancer chemotherapy, certain harmful microorganisms can multiply out of control and cause illness. Bacterial infection with [...]

By | June 10, 2016|News|

Video: Biosimilars

Biologics are very specific, highly effective medicines that improve health outcomes in inflammatory diseases, including Crohn’s disease and ulcerative colitis. Biosimilars are products that are similar to an innovator biologic, but not identical.   Biosimilars Video For more information on biosimilars Read our article View our survey results

By | May 31, 2016|News|
Load More Posts